Evidence map›Paper›PMID 33258970›Full record

ArticleEuropean journal of pediatrics2021

Use of insulin pump therapy is associated with reduced hospital-days in the long-term: a real-world study of 48,756 pediatric patients with type 1 diabetes.

Marie Auzanneau, Beate Karges, Andreas Neu, Thomas Kapellen, Stefan A Wudy, Corinna Grasemann, Gabriele Krauch, Eva Maria Gerstl, Gerhard Däublin, Reinhard W Holl

Open access · hybridAbstract read
In one paragraph

Article in European journal of pediatrics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Determinants, implementation strategies, and mechanisms of the 4T Program.Journal of clinical & translational endocrinology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 7 institutions in 1 country.

Marie AuzanneauInstitute of Epidemiology and Medical Biometry, ZIBMT, University of Ulm, Albert-Einstein-Allee 41, D-89081, Ulm, Germany. marie.auzanneau@uni-ulm.de.ORCID https://orcid.org/0000-0002-5906-6579
Beate KargesDivision of Endocrinology and Diabetes, Medical Faculty, RWTH Aachen University, Aachen, Germany.
Andreas NeuUniversity Children's Hospital Tübingen, Tübingen, Germany.
Thomas KapellenDepartment of Women and Child Health, Hospital for Children and Adolescents, University of Leipzig, Leipzig, Germany.
Stefan A WudyDivision of Pediatric Endocrinology and Diabetology, Center of Child and Adolescent Medicine, Justus Liebig University, Giessen, Germany.
Corinna GrasemannSt. Josef-Hospital, Klinikum der Ruhr-Universität, Bochum, Germany.
Gabriele KrauchDivision of Pediatric Endocrinology and Diabetology, Center of Child and Adolescent Medicine, University Medicine, Mannheim, Germany.
Eva Maria GerstlChildren's Hospital Passau, Passau, Germany.
Gerhard DäublinChildren's Hospital Aurich, Aurich, Germany.
Reinhard W HollInstitute of Epidemiology and Medical Biometry, ZIBMT, University of Ulm, Albert-Einstein-Allee 41, D-89081, Ulm, Germany.
Universität Ulm · DEJustus-Liebig-Universität Gießen · DEKlinikum Passau · DERWTH Aachen University · DESt. Josef-Hospital · DEUniversity Children's Hospital Tübingen · DEUniversity of Mannheim · DE

Funding

Deutsches Zentrum für Diabetesforschung (DZD) 82DZD0017G
6 · The paper itself

Abstract

In pediatric diabetes, insulin pump therapy is associated with less acute complications but inpatient pump education may lead to more hospital days. We investigated the number of hospital days associated with pump vs. injection therapy between 2009 and 2018 in 48,756 patients with type 1 diabetes < 20 years of age from the German Diabetes Prospective Follow-up Registry (DPV). Analyses were performed separately for hospitalizations at diagnosis (hierarchical linear models adjusted for sex, age, and migration), and for hospitalizations in the subsequent course of the disease (hierarchical Poisson models stratified by sex, age, migration, and therapy switch). At diagnosis, the length of hospital stay was longer with pump therapy than with injection therapy (mean estimate with 95% CI: 13.6 [13.3-13.9] days vs. 12.8 [12.5-13.1] days, P < 0.0001), whereas during the whole follow-up beyond diagnosis, the number of hospital days per person-year (/PY) was higher with injection therapy than with pump therapy (4.4 [4.1-4.8] vs. 3.9 [3.6-4.2] days/PY), especially for children under 5 years of age (4.9 [4.4-5.6] vs. 3.5 [3.1-3.9] days/PY).Conclusions: Even in countries with hospitalizations at diabetes diagnosis of longer duration, the use of pump therapy is associated with a reduced number of hospital days in the long-term. What is known: • In pediatric diabetes, insulin pump therapy is associated with better glycemic control and less acute complications compared with injection therapy. • However, pump therapy implies more costs and resources for education and management. What is new: • Even in countries where pump education is predominantly given in an inpatient setting, the use of pump therapy is associated with a reduced number of hospital days in the long-term. • Lower rates of hospitalization due to acute complications during the course of the disease counterbalance longer hospitalizations due to initial pump education.

Indexed as

Diabetes Mellitus, Type 1AdolescentChildChild, PreschoolHospitalsHumansHypoglycemic AgentsInsulinInsulin Infusion SystemsProspective StudiesYoung AdultHypoglycemic AgentsInsulinChildrenHospital daysHospitalizationInsulin pump therapyType 1 diabetes

Identifiers

PMID33258970
PMCPMC7813690
OpenAlexW3107574551

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.